Menopausal transition and depression: who is at risk and how to treat it?
- PMID: 17939767
- DOI: 10.1586/14737175.7.10.1285
Menopausal transition and depression: who is at risk and how to treat it?
Abstract
The menopausal transition may impose a challenge to clinicians and health professionals who are invested in improving women's quality of life; after all, this period in life is commonly marked by significant hormone fluctuations accompanied by bothersome vasomotor symptoms (e.g., hot flushes and night sweats) and other somatic complaints. In addition, more recent epidemiologic data demonstrate that some women transitioning to menopause may be at higher risk for developing depression when compared with their risk during premenopausal years; this increased risk appears to be true even among those who had never experienced depression before. In this article, putative contributing factors for this window of vulnerability for depression during the menopausal transition are critically reviewed. Hormonal and nonhormonal factors that may contribute to the occurrence of physical and/or psychiatric complaints during the menopausal transition are discussed. Lastly, existing evidence-based treatment strategies are summarized.
Similar articles
-
Diagnosis and management of mood disorders during the menopausal transition.Am J Med. 2005 Dec 19;118 Suppl 12B:93-7. doi: 10.1016/j.amjmed.2005.09.042. Am J Med. 2005. PMID: 16414333
-
Challenges and opportunities to manage depression during the menopausal transition and beyond.Psychiatr Clin North Am. 2010 Jun;33(2):295-308. doi: 10.1016/j.psc.2010.01.007. Psychiatr Clin North Am. 2010. PMID: 20385338 Review.
-
Quality of life impairment during the female menopausal transition is related to personal and partner factors.Gynecol Endocrinol. 2009 Feb;25(2):130-5. doi: 10.1080/09513590802617770. Gynecol Endocrinol. 2009. PMID: 19253110
-
Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles.Arch Gen Psychiatry. 2006 Apr;63(4):385-90. doi: 10.1001/archpsyc.63.4.385. Arch Gen Psychiatry. 2006. PMID: 16585467
-
Associations of hormones and menopausal status with depressed mood in women with no history of depression.Arch Gen Psychiatry. 2006 Apr;63(4):375-82. doi: 10.1001/archpsyc.63.4.375. Arch Gen Psychiatry. 2006. PMID: 16585466
Cited by
-
Reducing depression during the menopausal transition: study protocol for a randomised controlled trial.Trials. 2014 Aug 6;15:312. doi: 10.1186/1745-6215-15-312. Trials. 2014. PMID: 25095797 Free PMC article. Clinical Trial.
-
The protective effect of angiotensin II type I receptor blocker (valsartan) on behavioral impairment, NLRP3, BDNF, and oxidative stress in the brain tissue of ovariectomized female rats.Physiol Rep. 2024 Oct;12(20):e70003. doi: 10.14814/phy2.70003. Physiol Rep. 2024. PMID: 39443283 Free PMC article.
-
Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management.Drugs Aging. 2013 Sep;30(9):677-85. doi: 10.1007/s40266-013-0100-1. Drugs Aging. 2013. PMID: 23801148 Review.
-
Body image satisfaction and depression in midlife women: the Study of Women's Health Across the Nation (SWAN).Arch Womens Ment Health. 2014 Jun;17(3):177-87. doi: 10.1007/s00737-014-0416-9. Epub 2014 Mar 13. Arch Womens Ment Health. 2014. PMID: 24623160 Free PMC article.
-
Acupuncture as an Independent or Adjuvant Management to Standard Care for Perimenopausal Depression: A Systematic Review and Meta-Analysis.Front Psychiatry. 2021 May 28;12:666988. doi: 10.3389/fpsyt.2021.666988. eCollection 2021. Front Psychiatry. 2021. PMID: 34122180 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical